Achmea Investment Management B.V. Has $60.48 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Achmea Investment Management B.V. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.0% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 118,751 shares of the healthcare conglomerate’s stock after selling 2,367 shares during the quarter. UnitedHealth Group accounts for 1.1% of Achmea Investment Management B.V.’s holdings, making the stock its 9th biggest position. Achmea Investment Management B.V.’s holdings in UnitedHealth Group were worth $60,476,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Bell Investment Advisors Inc grew its stake in shares of UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares in the last quarter. Harbor Investment Advisory LLC grew its stake in shares of UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after acquiring an additional 1,129 shares in the last quarter. Austin Private Wealth LLC grew its stake in shares of UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares in the last quarter. Capital Insight Partners LLC boosted its holdings in shares of UnitedHealth Group by 3.8% in the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after buying an additional 332 shares during the last quarter. Finally, Collective Family Office LLC boosted its holdings in shares of UnitedHealth Group by 4.3% in the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after buying an additional 65 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 1.5 %

Shares of NYSE UNH opened at $589.75 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The stock has a market capitalization of $542.80 billion, a P/E ratio of 36.05, a PEG ratio of 1.66 and a beta of 0.58. The stock’s fifty day moving average is $564.99 and its 200 day moving average is $516.56.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the business earned $6.14 earnings per share. UnitedHealth Group’s revenue was up 6.4% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. TD Cowen increased their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Finally, Baird R W raised UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $614.17.

Get Our Latest Stock Analysis on UNH

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.